Head-to-head · WeighScore
Harmony Wellness Clinic vs Trimi
By GLP-1 ScorecardUpdated
Score comparison
Trimi has the higher recorded score — 86.4/100 to 60.9/100.
Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trimi combines compounded injections and care in monthly or prepaid plans; the annual discount is substantial, but prescription-issued refund limits deserve equal attention.
Before you choose
Before comparing the headline prices, the Harmony Wellness Clinic review and the Trimi review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Breeze Meds vs Harmony Wellness Clinic and HealthOn vs Trimi compare each of them with another graded program, and the list of alternatives to Harmony Wellness Clinic ranks the programs closest to Harmony Wellness Clinic on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Belle Health review covers one graded close to these two, at 73.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Harmony Wellness Clinic | Trimi |
|---|---|---|
| WeighScore | 60.9/100 | 86.4/100 |
| Grade | C | B |
| Site position | #336 | #8 |
| Semaglutide | $159/mo (monthly plan; $133/mo on a 3-month plan billed $399 upfront; same price at every dose, compounded) | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | $199/mo (monthly plan; $166.33/mo on a 3-month plan billed $499 upfront; same price at every dose, compounded) | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | 35 states and DC listed; confirm access | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes a flat price that does not rise with the dose
- Names pharmacy partners
What to consider
- The lower three-month rates are charged upfront
- Refund terms for a filled prescription remain unverified
Site position #8 · B
Strengths
- Separate semaglutide and tirzepatide plans include prescribed medication and care
- Monthly, quarterly, six-month and annual charges published
- BelieveRx pharmacy and Arora Health care network publicly named; individual assignment and licenses still need confirmation
- Supplies and shipping included under the published offer
What to consider
- Compounded injections only; no current branded or oral route
- Monthly and quarterly plans renew automatically; six-month and annual continuation needs a new confirmed purchase
- Ordinary orders become nonrefundable once the prescription is issued, even before shipping
- A named pharmacy partner does not independently verify the pharmacy assigned to your order
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.